Last updated: 22 July 2019 at 6:40am EST

Lee R Wrubel Net Worth




The estimated Net Worth of Lee R Wrubel is at least $9.98 Million dollars as of 19 May 2008. Lee Wrubel owns over 10,000 units of Atricure Inc stock worth over $7,685,787 and over the last 19 years Lee sold ATRC stock worth over $2,293,803.

Lee Wrubel ATRC stock SEC Form 4 insiders trading

Lee has made over 10 trades of the Atricure Inc stock since 2007, according to the Form 4 filled with the SEC. Most recently Lee sold 10,000 units of ATRC stock worth $110,000 on 19 May 2008.

The largest trade Lee's ever made was selling 49,000 units of Atricure Inc stock on 15 August 2007 worth over $500,290. On average, Lee trades about 14,915 units every 20 days since 2005. As of 19 May 2008 Lee still owns at least 285,717 units of Atricure Inc stock.

You can see the complete history of Lee Wrubel stock trades at the bottom of the page.



What's Lee Wrubel's mailing address?

Lee's mailing address filed with the SEC is 105 ROWAYTON AVENUE, , ROWAYTON, CT, 06853.

Insiders trading at Atricure Inc

Over the last 19 years, insiders at Atricure Inc have traded over $52,789,242 worth of Atricure Inc stock and bought 666,621 units worth $5,937,195 . The most active insiders traders include Scott William Drake, Group I, Llc Donoghue Danie..., and Management Group Viii L L C.... On average, Atricure Inc executives and independent directors trade stock every 24 days with the average trade being worth of $548,410. The most recent stock trade was executed by Maggie Yuen on 15 August 2024, trading 3,500 units of ATRC stock currently worth $84,245.



What does Atricure Inc do?

atricure, inc. provides innovative technologies for the treatment of afib and related conditions. afib affects more than 33 million people worldwide. electrophysiologists and cardiothoracic surgeons around the globe use atricure technologies for the treatment of afib and reduction of afib related complications. atricure’s isolator® synergy™ ablation system is the first and only medical device to receive fda approval for the treatment of persistent afib. atricure’s atriclip left atrial appendage exclusion system products are the most widely sold laa management devices worldwide, with more than 100,000 implanted to date. for more information, visit atricure.com or follow us on twitter @atricure.



Complete history of Lee Wrubel stock trades at Atricure Inc

Insider
Trans.
Transaction
Total value
Lee R Wrubel
Director
Sale $110,000
19 May 2008
Lee R Wrubel
Director
Sale $256,450
16 May 2008
Lee R Wrubel
Director
Sale $153,015
14 May 2008
Lee R Wrubel
Director
Sale $165,900
12 May 2008
Lee R Wrubel
Director
Sale $397,475
8 May 2008
Lee R Wrubel
Director
Sale $377,803
13 Mar 2008
Lee R Wrubel
Director
Sale $74,741
7 Mar 2008
Lee R Wrubel
Director
Sale $60,130
5 Mar 2008
Lee R Wrubel
Director
Sale $198,000
28 Nov 2007
Lee R Wrubel
Director
Sale $500,290
15 Aug 2007


Atricure Inc executives and stock owners

Atricure Inc executives and other stock owners filed with the SEC include: